Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

被引：0

作者：

Shigeki Nanjo

Akito Hata

Chiyuki Okuda

Reiko Kaji

Hideaki Okada

Daisuke Tamura

Kei Irie

Hiroshi Okada

Shoji Fukushima

Nobuyuki Katakami

机构：

[1] Institute of Biomedical Research and Innovation Hospital,Division of Integrated Oncology

[2] 2-2,Department of Medical Oncology

[3] Minatojima-minamimachi,Department of Respiratory Medicine

[4] Chuo-ku,Department of Pharmacology

[5] Kobe 650-0047,Department of Pharmaceutics

[6] Japan,undefined

[7] Kobe Minimally Invasive Cancer Center,undefined

[8] Kobe 650-0046,undefined

[9] Japan,undefined

[10] Kobe University Hospital,undefined

[11] Kobe 650-0017,undefined

[12] Japan,undefined

[13] Institute of Biomedical Research and Innovation Hospital,undefined

[14] Kobe 650-0047,undefined

[15] Japan,undefined

[16] Faculty of Pharmaceutical Science,undefined

[17] Kobe Gakuin University,undefined

[18] Kobe 650-8586,undefined

[19] Japan,undefined

来源：

British Journal of Cancer | 2018年 / 118卷

关键词：

osimertinib; leptomeningeal metastases; T790M; cerebrospinal fluid;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：32 / 37

页数：5

共 50 条

[31] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
Gen, Soei
Tanaka, Ichidai
Morise, Masahiro
Koyama, Junji
Kodama, Yuta
Matsui, Akira
Miyazawa, Ayako
Hase, Tetsunari
Hibino, Yoshitaka
Yokoyama, Toshihiko
Kimura, Tomoki
Yoshida, Norio
Sato, Mitsuo
Hashimoto, Naozumi
[J]. BMC CANCER, 2022, 22 (01)
[32] Clinical efficacy of osimertinib in EGFR-mutant non-small cell lung cancer with distant metastasis
Soei Gen
Ichidai Tanaka
Masahiro Morise
Junji Koyama
Yuta Kodama
Akira Matsui
Ayako Miyazawa
Tetsunari Hase
Yoshitaka Hibino
Toshihiko Yokoyama
Tomoki Kimura
Norio Yoshida
Mitsuo Sato
Naozumi Hashimoto
[J]. BMC Cancer, 22
[33] Weight loss in patients on osimertinib for metastatic EGFR-mutant non-small cell lung cancer
Chen, Lanyi Nora
Ma, Xin
Herzberg, Benjamin
Henick, Brian S.
Biswas, Anup K.
Acharyya, Swarnali
Shu, Catherine A.
[J]. ONCOLOGIST, 2024,
[34] Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study
Zhou, Qing
Zhang, He-Long
Jiang, Li-Yan
Shi, Yuan-Kai
Chen, Yuan
Yu, Jin-Ming
Zhou, Cai-Cun
He, Yong
Hu, Yan-Ping
Liang, Zong-An
Pan, Yue-Yin
Zhuo, Wen-Lei
Song, Yong
Wu, Gang
Chen, Gong-Yan
Lu, You
Zhang, Cui-Ying
Zhang, Yi-Ping
Cheng, Ying
Lu, Shun
Wang, Chang-Li
Zhou, Jian-Ying
Liu, Yun-Peng
He, Jian-Xing
Wang, Jie
Wu, Yi-Long
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10771 - 10780
[35] Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study
Qing Zhou
He-Long Zhang
Li-Yan Jiang
Yuan-Kai Shi
Yuan Chen
Jin-Ming Yu
Cai-Cun Zhou
Yong He
Yan-Ping Hu
Zong-An Liang
Yue-Yin Pan
Wen-Lei Zhuo
Yong Song
Gang Wu
Gong-Yan Chen
You Lu
Cui-Ying Zhang
Yi-Ping Zhang
Ying Cheng
Shun Lu
Chang-Li Wang
Jian-Ying Zhou
Yun-Peng Liu
Jian-Xing He
Jie Wang
Yi-Long Wu
[J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10771 - 10780
[36] Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer
Tozuka, Takehiro
Noro, Rintaro
Miyanaga, Akihiko
Nakamichi, Shinji
Takeuchi, Susumu
Matsumoto, Masaru
Kubota, Kaoru
Kasahara, Kazuo
Seike, Masahiro
[J]. CANCER MEDICINE, 2023, 12 (17): : 17731 - 17739
[37] Treatment Response To Osimertinib In EGFR-Mutated Leptomeningeal Metastases From Non-Small Cell Lung Cancer: A Case Series
Li, Huiying
Yu, Tingting
Huang, Mingmin
Guo, Aibin
Qian, Xiaoping
Yin, Zhenyu
[J]. ONCOTARGETS AND THERAPY, 2019, 12 : 7785 - 7790
[38] Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan
Ohe, Yuichiro
Kato, Terufumi
Sakai, Fumikazu
Kusumoto, Masahiko
Endo, Masahiro
Saito, Yoshinobu
Baba, Tomohisa
Sata, Masafumi
Yamaguchi, Ou
Sakamoto, Kei
Sugeno, Masatoshi
Tamura, Reiko
Tokimoto, Toshimitsu
Shimizu, Wataru
Gemma, Akihiko
[J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (08) : 909 - 919
[39] Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer
Jan A. Stratmann
Sebastian Michels
Sofia Hornetz
Daniel C. Christoph
Sandra Sackmann
Werner Spengler
Helge Bischoff
Monica Schäfer
Jürgen Alt
Annette Müller
Eckart Laack
Martin Kimmich
Frank Griesinger
Martin Sebastian
[J]. Journal of Cancer Research and Clinical Oncology, 2018, 144 : 2457 - 2463
[40] Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer
Stratmann, Jan A.
Michels, Sebastian
Hornetz, Sofia
Christoph, Daniel C.
Sackmann, Sandra
Spengler, Werner
Bischoff, Helge
Schaefer, Monica
Alt, Juergen
Mueller, Annette
Laack, Eckart
Kimmich, Martin
Griesinger, Frank
Sebastian, Martin
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (12) : 2457 - 2463

← 1 2 3 4 5 →